BioMed Research International / 2013 / Article / Fig 3

Research Article

2-Heptyl-Formononetin Increases Cholesterol and Induces Hepatic Steatosis in Mice

Figure 3

Development of hepatic steatosis in C57BL/6 mice fed chow, cholesterol, or cholesterol supplemented with formononetin or 2-heptyl-formonetin (C7F) for five weeks (Experiment  2). (A) Weight of liver ( ). (B) Triglyceride content in liver ( ). Total lipids were extracted from liver using a modified version of the Bligh and Dyer protocol, and the content of triglyceride were analysed with a commercial kit. (C) Liver sections stained with hematoxylin and eosin. (D) Hepatic gene expression of Tnf (tumour necrosis factor ) measured by RT-PCR. Data is normalised to 18S ribosomal RNA and presented relatively to the expression in chow ( ). (E) Plasma level of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ( ). Graphs show mean ± SEM. Different letters (a, b) denote significant difference ( ) between the groups.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.